APA

Inoue I., Nakajima T., Williams C. S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig E. H., Sharma A. M., Hata A., Jeunemaitre X. & Lalouel J. M. (19970424). A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. : The Journal of clinical investigation.

Chicago

Inoue I, Nakajima T, Williams C S, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig E H, Sharma A M, Hata A, Jeunemaitre X and Lalouel J M. 19970424. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. : The Journal of clinical investigation.

Harvard

Inoue I., Nakajima T., Williams C. S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig E. H., Sharma A. M., Hata A., Jeunemaitre X. and Lalouel J. M. (19970424). A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. : The Journal of clinical investigation.

MLA

Inoue I, Nakajima T, Williams C S, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig E H, Sharma A M, Hata A, Jeunemaitre X and Lalouel J M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. : The Journal of clinical investigation. 19970424.